Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -299,410 | -120,854 | -446,214 | -334,259 | -226,219 |
| Depreciation Amortization | 606 | 279 | 214 | 81 | -74 |
| Accounts payable and accrued liabilities | 14,159 | -4,804 | 8,251 | 17,714 | -756 |
| Other Working Capital | -4,825 | -37,623 | -3,404 | 7,907 | 2,039 |
| Other Operating Activity | 14,262 | 18,080 | 37,946 | 17,182 | 24,414 |
| Operating Cash Flow | $-275,208 | $-144,922 | $-403,207 | $-291,375 | $-200,596 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -107,064 | -64,278 | -180,534 | -153,823 | -106,903 |
| PPE Investments | -1,735 | -221 | -1,920 | -1,436 | -1,041 |
| Purchase Of Investment | 58,190 | 33,459 | 154,642 | 135,847 | 107,708 |
| Sale Of Investment | 43,422 | 28,648 | 17,851 | 8,469 | 8,468 |
| Other Investing Activity | 0 | 0 | -18,790 | -18,790 | 0 |
| Investing Cash Flow | $-7,187 | $-2,392 | $-28,751 | $-29,733 | $8,232 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 18,034 | 6,786 | N/A | N/A | N/A |
| Debt Issued | 49,450 | N/A | 148,256 | 98,802 | 98,802 |
| Common Stock Issued | 2,048 | 1,311 | 742,609 | 361,089 | 143,213 |
| Other Financing Activity | -4,358 | -1,033 | -558 | -549 | 0 |
| Financing Cash Flow | $65,174 | $7,064 | $890,307 | $459,342 | $242,015 |
| Beginning Cash Position | 895,740 | 895,740 | 437,391 | 437,391 | 437,391 |
| End Cash Position | 678,519 | 755,490 | 895,740 | 575,625 | 487,042 |
| Net Cash Flow | $-217,221 | $-140,250 | $458,349 | $138,234 | $49,651 |
| Free Cash Flow | |||||
| Operating Cash Flow | -275,208 | -144,922 | -403,207 | -291,375 | -200,596 |
| Capital Expenditure | -1,735 | -221 | -1,920 | -1,436 | -1,041 |
| Free Cash Flow | -276,943 | -145,143 | -405,127 | -292,811 | -201,637 |